Am J Physiol Cell Physiol AJP: Lung Cellular and Molecular Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Cell Physiol 289: C1229-C1239, 2005. First published June 22, 2005; doi:10.1152/ajpcell.00620.2004
0363-6143/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
289/5/C1229    most recent
00620.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuldo, J. M.
Right arrow Articles by Molema, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuldo, J. M.
Right arrow Articles by Molema, G.

VASCULAR BIOLOGY

Differential effects of NF-{kappa}B and p38 MAPK inhibitors and combinations thereof on TNF-{alpha}- and IL-1{beta}-induced proinflammatory status of endothelial cells in vitro

Joanna M. Kuldo,1 Johanna Westra,2 Sigridur A. Ásgeirsdóttir,1 Robbert J. Kok,3 Koen Oosterhuis,4 Marianne G. Rots,4 Jan P. Schouten,5 Pieter C. Limburg,2 and Grietje Molema1

1Endothelial Cell and Vascular Drug Targeting Group, Medical Biology Section, Department of Pathology and Laboratory Medicine, 2Department of Rheumatology, 3Department of Pharmacokinetics and Drug Delivery, 4Department of Therapeutic Gene Modulation, and 5Department of Epidemiology and Bioinformatics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

Submitted 17 December 2004 ; accepted in final form 14 June 2005

Endothelial cells actively participate in inflammatory events by regulating leukocyte recruitment via the expression of inflammatory genes such as E-selectin, VCAM-1, ICAM-1, IL-6, IL-8, and cyclooxygenase (COX)-2. In this study we showed by real-time RT-PCR that activation of human umbilical vein endothelial cells (HUVEC) by TNF-{alpha} and IL-1{beta} differentially affected the expression of these inflammatory genes. Combined treatment with TNF-{alpha} and IL-1{beta} resulted in nonadditive, additive, and even synergistic induction of expression of VCAM-1, IL-8, and IL-6, respectively. Overexpression of dominant-negative inhibitor {kappa}B protein blocking NF-{kappa}B signaling confirmed a major role of this pathway in controlling both TNF-{alpha}- and IL-1{beta}-induced expression of most of the genes studied. Although dexamethasone exerted limited effects at 1 µM, the thioredoxin inhibitor MOL-294, which regulates the redox state of NF-{kappa}B, mainly inhibited adhesion molecule expression. Its most pronounced effect was seen on VCAM-1 mRNA levels, especially in IL-1{beta}-activated endothelium. One micromolar RWJ-67657, an inhibitor of p38 MAPK activity, diminished TNF-{alpha}- and IL-1{beta}-induced expression of IL-6, IL-8, and E-selectin but had little effect on VCAM-1 and ICAM-1. Combined treatment of HUVEC with MOL-294 and RWJ-67657 resulted in significant blocking of the expression of E-selectin, IL-6, IL-8, and COX-2. The inhibitory effects were much stronger than those observed with single drug treatment. Application of combinations of drugs that affect multiple targets in activated endothelial cells may therefore be considered as a potential new therapeutic strategy to inhibit inflammatory disease activity.

inflammatory gene expression; anti-inflammatory drugs; pharmacology; combination treatment



Address for reprint requests and other correspondence: G. Molema, University Medical Center Groningen, Dept. of Pathology and Laboratory Medicine, Medical Biology section, Hanzeplein 1, 9713 GZ Groningen, The Netherlands (e-mail: g.molema{at}med.umcg.nl)




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. Matsumura, T. Shibakusa, T. Fujikawa, H. Yamada, K. Matsumura, K. Inoue, and T. Fushiki
Intracisternal administration of transforming growth factor- evokes fever through the induction of cyclooxygenase-2 in brain endothelial cells
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2008; 294(1): R266 - R275.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
L. Nonn, D. Duong, and D. M. Peehl
Chemopreventive anti-inflammatory activities of curcumin and other phytochemicals mediated by MAP kinase phosphatase-5 in prostate cells
Carcinogenesis, June 1, 2007; 28(6): 1188 - 1196.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
F. Theilig, W. Kriz, T. Jerichow, P. Schrade, B. Hahnel, T. Willnow, M. Le Hir, and S. Bachmann
Abrogation of Protein Uptake through Megalin-Deficient Proximal Tubules Does Not Safeguard against Tubulointerstitial Injury
J. Am. Soc. Nephrol., June 1, 2007; 18(6): 1824 - 1834.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
T. Morrison, J. Hurley, J. Garcia, K. Yoder, A. Katz, D. Roberts, J. Cho, T. Kanigan, S. E. Ilyin, D. Horowitz, et al.
Nanoliter high throughput quantitative PCR
Nucleic Acids Res., October 6, 2006; 34(18): e123 - e123.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.